Clinical Trial Update: Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluated the safety and efficacy of bosutinib in combination with atezolizumab in adults with newly diagnosed chronic myeloid leukemia in chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Phase Chronic Myeloid Leukemia

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bosutinib (bosutinib)

Snippet

Sponsor: Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica | Conditions: Chronic Phase-Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-03-12